A study published in JAMA Internal Medicine finds semaglutide, a weight loss medication, does not increase depressive symptoms or suicidal behavior in individuals without known mental health disorders ...

3, 2024 (HealthDay News) -- The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. But a new study ...

Studies found that semaglutide reduced inflammation regardless of whether users lost weight, The Times of London reported. Weight-loss drugs such as Ozempic come with a risk of severe side effects.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without ...

Semaglutide, better known as Ozempic, "has far-reaching benefits beyond what we initially imagined," Prof Harlan Krumholz, from the Yale School of Medicine, said following the publication of ...

These two injected drugs are versions of semaglutide. In multiple new data analyses, the drugs appeared to cut people's odds for heart failure and its complications, reduce deaths from COVID-19 and ...

After a regulatory hiccup earlier this month, Novo Nordisk’s heart failure ambitions for its obesity star Wegovy (semaglutide) are starting to get back on track. Novo’s semaglutide cut the ...

LON­DON — Af­ter a re­cent spate of set­backs, No­vo Nordisk has raised the cur­tain on da­ta de­tail­ing semaglu­tide’s abil­i­ty to cut the risk of heart fail­ure … ...

These two injected drugs are versions of semaglutide. In multiple new data analyses, the drugs appeared to cut people's odds for heart failure and its complications, reduce deaths from COVID-19 ...

There is significant disproportionality for semaglutide-associated suicidal ideation, relative to all medications. Semaglutide – but not liraglutide – is associated with disproportionately ...